For: | Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27(26): 4104-4142 [PMID: 34326614 DOI: 10.3748/wjg.v27.i26.4104] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i26/4104.htm |
Number | Citing Articles |
1 |
Toyokazu Saito, Satoshi Takakusagi, Hitoshi Takagi, Youzo Yokoyama, Kazuko Kizawa, Kyoko Marubashi, Takashi Kosone, Hiroki Kiyohara, Kei Shibuya, Toshio Uraoka. Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy. Clinical Journal of Gastroenterology 2023; 16(2): 216 doi: 10.1007/s12328-022-01734-1
|
2 |
Takanori Ito, Mindie H Nguyen. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes. Journal of Hepatocellular Carcinoma 2023; : 413 doi: 10.2147/JHC.S347959
|
3 |
Erlintan Sinaga, Uswatun Hasanah, Feimmy Ruth Pratiwi Sipahutar. Chemopreventive potential of Saurauia vulcani korth in improving Rhodamine B induced hepato-renal carcinoma in Rats. Pharmacological Research - Modern Chinese Medicine 2023; 9: 100336 doi: 10.1016/j.prmcm.2023.100336
|
4 |
Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo, Xing Lai, Fu Wang. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/6535009
|
5 |
Wu-Po Chao, Shion-Wei Chai, Po-Hsing Chiang, Ta-Chun Chou, Yi-Chan Chen, Ruey-Shyang Soong. Should we change the treatment plan in early hepatocellular carcinoma with chronic kidney disease?. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-01983-y
|
6 |
Samantha M. Ruff, Alexander H. Shannon, Joal D. Beane, Timothy M. Pawlik. Highlighting novel targets in immunotherapy for liver cancer. Expert Review of Gastroenterology & Hepatology 2022; 16(11-12): 1029 doi: 10.1080/17474124.2022.2150841
|
7 |
Wen-Rui Hao, Tsung-Yeh Yang, Chun-Chao Chen, Kuan-Jie Lin, Chun-Chih Chiu, Yu-Ann Fang, William Jian, Meng-Huan Lei, Hsien-Tang Yeh, Min-Huei Hsu, Nai-Hsuan Chen, Hung-Chang Jong, Jing-Quan Zheng, Ju-Chi Liu. Influenza Vaccination Reduces the Risk of Liver Cancer in Patients with Chronic Kidney Disease: A Nationwide Population-Based Cohort Study. Vaccines 2022; 10(12): 2008 doi: 10.3390/vaccines10122008
|
8 |
Chia-Chu Fu, Yu-Jen Chen, Chien-Wei Su, Cheng-Yi Wei, Chi-Jen Chu, Pei-Chang Lee, Teh-Ia Huo, Yi-Hsiang Huang, Hui-Chun Huang, Jaw-Ching Wu, Ming-Chih Hou. The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B. Journal of the Chinese Medical Association 2023; 86(10): 876 doi: 10.1097/JCMA.0000000000000975
|
9 |
Shalin Abraham, Adel Samson. Case report: Successful treatment of a patient undergoing haemodialysis with multifocal hepatocellular carcinoma using atezolizumab and bevacizumab. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1279501
|
10 |
Chao Chen, Zhinan Xie, Ying Ni, Yuxi He. Screening immune-related blood biomarkers for DKD-related HCC using machine learning. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339373
|
11 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
12 |
Xinnan Wu, Guangwen Luo, Zhaonian Dong, Wen Zheng, Gengjie Jia. Integrated Pleiotropic Gene Set Unveils Comorbidity Insights across Digestive Cancers and Other Diseases. Genes 2024; 15(4): 478 doi: 10.3390/genes15040478
|
13 |
Deok-Gie Kim, Shin Hwang, Jong Man Kim, Je Ho Ryu, Young Kyoung You, Donglak Choi, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Tae-Seok Kim, Jai Young Cho, Geun Hong, Jae Do Yang, Jaryung Han, Suk-Won Suh, Kwan Woo Kim, Yun Kyung Jung, Ju Ik Moon, Jun Young Lee, Sung Hwa Kim, Jae Geun Lee, Myoung Soo Kim, Kwang-Woong Lee, Dong Jin Joo. Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month. Journal of Clinical Medicine 2022; 11(14): 4203 doi: 10.3390/jcm11144203
|